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PRE-SURGICAL CONSIDERATIONS 
 
•  Coagulation: Prolongation of  PT and PTT can be treated with 
preoperative vitamin K1 for 24 hours prior to surgery or 
administration of  fresh frozen plasma or cryoprecipitate. 
•  Biochemistry: é ALT, ALP, GGT, albumin. 
•  Hypoglycemia: It appears if  70% of  the hepatic mass is removed. 
•  Anesthesia: Hepatic biotransformation P-450 and prolonged drug 
effects. High levels of  capnoghraphy are needed to avoid 
vasoconstriction. 
INTRODUCTION and OBJECTIVES 
 
•  Liver tumors are one of  the reasons for surgical intervention with 
nonspecific signs. 
•  Regeneration of  hepatic tissue to restore a normal liver function 
is possible after removal of  70%-80% of  the hepatic mass. 
•  The objective of  this final degree project its to make a literature 
review about hepatic lobectomy and their challenges adding the 
acquired experience in HCV. 
HEPATIC NEOPLASIA 
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IMAGE DIAGNOSIS 
 
Abdominal 
ultrasound with 
HCC mass 
•  Abdominal radiography 
•  Abdominal ultrasound 
•  TC 
•  MRI 
SURGICAL TECHNIQUE 
 
COMPLICATIONS and POSTOPERATIVE CARE 
D 
The main potential complication of  this procedure is hemorrhage: 
•  Direct pressure 
•  Pringle’s maneuver 
Other complications are portal hypertension, hepatic insufficiency, 
hypoglycemia, thromboembolism. 
 
Postoperative care: ECG monitoring (ventricular arrhythmias), 
hematocrit, albumin, electrolytes, hypotension, among others. 
Analgesia: with fentanyl, morphine or buprenorphine. 
Antibiotics are usually not necessary. 
 
•  Median survival times are 1460 days in dogs witb surgical 
treatment. 
•  Tumor recurrence is rare and reported to be 0% to 13% after liver 
lobectomy.  
•  Poor prognosis signs: lack of  surgical treatment, é ALT, ALP, 
ASP, AST and ALT: AST ratios, and right-sided mass location and 
postoperative hypotension. 
 
 
  
•  Hepatic lobectomy currently achieves greater surgical success thanks to the incorporation of  new devices, suchs as TA stapler. 
•  Dogs tolerate extended hepatectomy, with up to 90% of  the hepatic mass being excised. 
•  Larger hilar tumors or those surrounding the caudal vena cava or portal vein are particularly difficult to extract. 
•  Patients undergoing right or extended lobectomies have the highest mortality rates. 
•  Chemotherapy has poor effectiveness for primary liver tumors. 
•  Subtotal removal does affect survival because more aggressive and invasive components are found at the periphery of  the tumor. 
•  CT reveals the invasion of  several lobes giving an erroneous result, because the surgery shows a single location. 
 
 
1.  Cranial two-thirds midline laparotomy. 
2.  Expose hepatic artery and hepatic biliary 
duct located in the hepatoduodenal 
ligament. 
3.  Location of  the branch of  portal and 
hepatic vein and ligation of  the portal 
branch. 
4.  Triangular ligament is separated. 
5.  V3 TA30 application in the lateral 
hepatic vein and remanent tissue. 
LEFT DIVISION 
CENTRAL DIVISION 
•  Complete removal necessitates removal of  both lobes, right 
medial and quadrate, together.  
•  The gallbladder can be preserved if  the tumor is not associated 
with this structure. 
•  To prevent torsion of  the adjacent lobes, a coating omentum can 
be made. 
PROGNOSIS 
	
CONCLUSIONS 
	
•  There are 4 types of  primary 
hepatic neoplasia, being the most 
common the hepatocellular tumor 
(hepatocellular carcinoma or 
HCC). 
